<b>Two Cases of Intractable Septic Arthritis and Osteomyelitis </b><b>Effectively Treated with Tonifying Formulae</b>

Bibliographic Information

Other Title
  • <b>難治性骨・関節感染症に対して </b><b>補剤が有効であった2症例</b>
  • 臨床報告 難治性骨・関節感染症に対して補剤が有効であった2症例
  • リンショウ ホウコク ナンチセイコツ ・ カンセツ カンセンショウ ニ タイシテ ホザイ ガ ユウコウ デ アッタ 2 ショウレイ
  • Two Cases of Intractable Septic Arthritis and Osteomyelitis Effectively Treated with Tonifying Formulae

Search this article

Abstract

We experienced 2 cases in which Kampo (Chinese medicine) treatment was effective for septic osteoarthritis. Case 1 : a 34-year-old female. Septic coxarthritis developed with no left hip joint abnormality being noted, while DIC (disseminated intravascular coagulation) from MRSA pneumonia was treated. Surgeries were carried out five times, but there was no wound closure, and exudate discharge continued. At first, she was treated with Hochuekkito, did not run a fever, and good granulation tissue was formed in the wound. After a change to Senkinnaitakusan, exudate quantity decreased. Moreover, after an external fixation operation and being treated with Juzentaihoto, epithelization progressed, and the wound eventually closed. Case 2 : a 79-year-old female. One year and 6 months after osteosynthesis with compression hip screw was carried out for a femoral neck fracture, operation scar complications and large quantities of exudate were seen, so we diagnosed her with late onset septic osteomyelitis. She gained weight with Juzentaihoto treatment, while a decrease in exudates and fistula closure with Astragali Radix and Ginseng Radix were confirmed by MRI, and her nutritional state improved. Generally speaking, septic arthritis and osteomyelitis are difficult to treat, but Kampo medicines were curatively effective for these diseases, particularly when increasing Astragali Radix and Ginseng Radix quantity.

Journal

  • Kampo Medicine

    Kampo Medicine 64 (1), 32-40, 2013

    The Japan Society for Oriental Medicine

Citations (3)*help

See more

References(8)*help

See more

Details 詳細情報について

Report a problem

Back to top